GLP-1 Medications · AustraliaGLP-1 Refill Reminders in Australia,
Ozempic, Wegovy and Mounjaro
Managing a weekly GLP-1 injection in Australia is more complex than most medications. Between PBS availability, repeat script timing, and weekly dosing, it's easy to fall behind. Here's how to make sure you stay ahead of your repeats.
MediRemind tracks your GLP-1 scripts and sends refill reminders before you run out. Available with a 30-day trial, then a subscription.
Why GLP-1 prescriptions need extra attention
GLP-1 receptor agonists, including Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide) and Trulicity (dulaglutide), are weekly injection medications. Unlike a daily tablet that quickly becomes routine, a weekly injection is easier to lose track of, and running out mid-cycle disrupts your treatment.
There are three specific challenges Australians on GLP-1 therapy face:
PBS supply fluctuations
Availability of Mounjaro and Wegovy has been inconsistent in Australia. Running out because you couldn't get a timely repeat is compounded when supply at pharmacies is already limited.
Repeat script timing
You need to request repeats in advance of running out, which requires GP appointment planning. With busy GPs and wait times, leaving this to the last minute risks a treatment gap.
Dose escalation schedules
Many patients move through different dose strengths, 2.5mg, 5mg, 7.5mg, 10mg, requiring new scripts at each stage. Keeping track of where you are in the escalation schedule matters.
Current PBS status for GLP-1 medications in Australia (2026)
| Medication | PBS Status | Notes |
|---|---|---|
| Ozempic (semaglutide) | PBS-listed (type 2 diabetes) | Private prescription for weight management. Supply has been limited. |
| Wegovy (semaglutide) | Not PBS-listed (July 2026) | Private prescription only. PBAC positive recommendation issued November 2025. No listing date confirmed. |
| Mounjaro (tirzepatide) | Not PBS-listed (1 Sep 2026) | March 2026 PBAC recommendation did not result in a listing. Official status says the listing process ceased because the manufacturer did not proceed. |
| Trulicity (dulaglutide) | PBS-listed (type 2 diabetes) | Weekly injection. Established supply in Australia. |
Note: PBS eligibility and listing status change. Always verify current criteria with your GP and at pbs.gov.au.
Prices vary between pharmacies, use the no-cost MediRemind PBS Cost Calculator to find your exact out-of-pocket cost for Ozempic, Wegovy, or Mounjaro.
Track your Ozempic, Wegovy or Mounjaro repeats, get reminders before you run out
No-cost · No pharmacy lock-in · iOS and Android
The auto-refill problem in Australia
Unlike the United States where pharmacies can offer automatic refills, Australia requires a valid prescription each time you collect. This means Australians on GLP-1 therapy need to actively manage their repeat scripts to avoid treatment gaps.
Patient uses their last injection pen without requesting a repeat in advance
GP appointment takes several days to arrange
There is a gap in treatment, sometimes 1–2 weeks
Treatment momentum is disrupted, with potential impact on glycaemic control or weight management progress
How MediRemind helps Australians on GLP-1 therapy
Weekly injection reminders
Set a weekly reminder for the same day each week, Monday morning, Sunday evening, whatever suits your routine. MediRemind sends a push notification so your GLP-1 injection becomes as automatic as possible.
Repeat script tracking
MediRemind tracks how many repeats you have remaining on your GLP-1 prescription and alerts you when you're on your last repeat, so you know to book a GP appointment before you run out entirely.
eScript storage
Store your GLP-1 eScript token directly in MediRemind so it's always accessible at the pharmacy, no hunting through SMS messages or emails when you need to collect.
Family and carer profiles
Managing medications for a family member on GLP-1 therapy? Add a separate profile for them in MediRemind and manage their scripts and reminders alongside your own.
Frequently asked questions
Is Ozempic available in Australia for weight loss in 2026?
Ozempic is PBS-listed in Australia for eligible type 2 diabetes patients. It is not PBS-listed for weight management. Wegovy (semaglutide at a higher dose) is TGA-approved for weight management but is not yet PBS-listed as of July 2026, all patients pay private rates. Discuss your specific situation with your GP.
Is Wegovy on the PBS in Australia?
No. As of July 2026, Wegovy is not PBS-listed for weight management in Australia. All patients pay the full private cost regardless of Medicare or concession status. The PBAC issued a positive recommendation in November 2025 for a narrow patient group, but no PBS listing date has been confirmed. Check pbs.gov.au or speak to your GP for the latest.
Can I get Mounjaro on the PBS in Australia?
No. As of 1 September 2026, Mounjaro (tirzepatide) is not PBS-listed for any indication in Australia. The official status record says the listing process has ceased because the manufacturer did not proceed. Patients pay the private price. Speak to your GP about your options.
What is the best app for managing GLP-1 injections in Australia?
MediRemind is an Australian-built app that combines eScript tracking, medication reminders, and repeat script alerts in one place. Set weekly injection reminders, track your PBS repeats, and store your eScript tokens. available with a 30-day trial, then a subscription.
How do I set up weekly injection reminders for Ozempic or Wegovy?
Download MediRemind, add your GLP-1 medication, and set the frequency to weekly. Choose your preferred injection day and time. MediRemind will send you a push notification every week on that day, keeping your injection schedule consistent without relying on memory alone.
How much does Ozempic or Wegovy cost on the PBS vs privately in Australia?
On the PBS, eligible patients pay around $25.00 per month (general) or $7.70 (concession). Without PBS eligibility, Ozempic can be $300–$400/month and Wegovy $300–$500/month privately. Use the no-cost PBS Medication Cost Calculator at mediremind.com.au/pbs-medication-cost-calculator-australia to compare PBS and private prices across GLP-1 medications.
How do I find out exactly what my medication will cost?
Use the no-cost MediRemind PBS Cost Calculator at mediremind.com.au/pbs-medication-cost-calculator-australia. Enter your medication name and it shows you the current PBS co-payment, private prescription price, concession rate, and Safety Net threshold, all in one place.
References to weight management medications on this page are for general information only. MediRemind does not prescribe, supply or endorse any specific medication. Individual circumstances vary, speak to your doctor about which treatment is appropriate for you.
Related guides
Keep your GLP-1 schedule and repeats organised.
Track your Ozempic, Wegovy or Mounjaro scripts and get refill reminders before you run out. Available with a 30-day trial, then a subscription.